Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Molecular Diagnostics Market to Cross US$ 10 Billion by 2021

Market Research Engine
Posted on: 02 Oct 16
Molecular Diagnostics Market to Cross US$ 10 Billion by 2021

New York, October 03: Market Research Engine has published a new report titled as “Molecular Diagnostics Market by Application, Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2023”

The molecular diagnostics market is expected to exceed more than US$ 10 Billion by 2021 growing at around 9% CAGR during the forecast period.

Download Free Sample Report:

Molecular diagnostics is a technique used to analyse, diagnose, monitor and treat disease. Using molecular diagnostics process it identify a disease by examining different molecules such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), protein and in tissue. Molecular diagnostics are primarily used for healthcare diagnosis and also used for research purpose. Molecular diagnostics provide more accurate results and they are playing a vital role in health care system.

The main driving factors for molecular diagnostics market are increased awareness and usage of personalized medicine. The companion diagnostics will grow eventually with growth of personalized medicine which in turn will drive the molecular diagnostics products and services market. It contains high prevalence rate of infectious diseases and various types of cancer. The new biomarkers are developed using molecular techniques which are applied in molecular diagnostics. It increases the growth in proteomics and genomics research.The molecular diagnostics market has some restraints such as it require new tools which contain complex platforms which require skilled and experienced workers. Because of mandatory training and complex regulatory framework gives delay approvals of new molecular diagnostic tests.

Browse Full Report:

The molecular diagnostics market is segmented by product, by technology, by application and by end user analysis. Under the product and service segmentation it contains instruments, reagents and services & software. It uses different technologies such as polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA sequencing and next-generation sequencing, microarrays, mass pectrometry, flow cytometry, and electrophoresis. Molecular diagnostics techniques are used in different application such as infectious diseases, oncology, genetics, blood screening, microbiology, cardiovascular diseases, neurological diseases, and DNA fingerprinting. The end user of molecular diagnostics are reference laboratories, hospital laboratories, blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing. The molecular diagnostics market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for molecular diagnostics and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023.
3) Identifications of new market opportunities and targeted promotional plans for molecular diagnostics.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The scope of the report includes a detailed study of global and regional markets for various types of molecular diagnostics with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France), and Cepheid Inc. (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Molecular diagnostics Market has been segmented as below:  

By Product and service Segment Analysis

Services & Software
By Technology Analysis
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing and Next-generation Sequencing
Others (Mass Spectrometry, Flow Cytometry, and Electrophoresis)

By End-user Analysis

Reference Laboratories
Hospital Laboratories
Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point-of-care Settings, and Self-testing)

By Application Analysis

Infectious Diseases
Blood Screening
Others (Cardiovascular Diseases, Neurological Diseases, and DNA Fingerprinting)

By Regional Analysis

North America
Rest of the World

For more information:

Editor's Details

John Bay
Market Research Engine

Last updated on: 02/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.